Jennison Associates LLC Astrazeneca PLC Transaction History
Jennison Associates LLC
- $170 Billion
- Q3 2025
A detailed history of Jennison Associates LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Jennison Associates LLC holds 3,685,664 shares of AZN stock, worth $329 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
3,685,664
Previous 12,167,365
69.71%
Holding current value
$329 Million
Previous $850 Million
66.74%
% of portfolio
0.17%
Previous 0.51%
Shares
30 transactions
Others Institutions Holding AZN
# of Institutions
1,499Shares Held
500MCall Options Held
5.59MPut Options Held
3.18M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...